Lung Cancer Trial, Recruiting NCT07664579 Sponsor: City of Hope Medical Center Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT07664579
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a primary brain tumour (glioblastoma) or another type of cancer such as breast or lung cancer
  • People who are new patients at City of Hope (any location), or who receive at least some of their care at the City of Hope Duarte Campus — this includes procedures, consultations, lab tests, imaging, surgery, or treatment
  • People who are in a committed relationship or partnership where their partner is available and willing to take part in the study
  • People who speak English or Spanish
  • People who are 18 years of age or older
  • People who have access to a smartphone, computer, laptop, or internet connection to complete the study activities

Who may not be able to join:

  • People with significant difficulties with memory, thinking, or understanding
  • People who are currently receiving inpatient psychiatric treatment for a severe mental illness, or who show clear signs of severe mental health conditions such as psychosis
  • People whose vision, hearing, speech, or physical movement makes it impossible to complete the study procedures, based on a clinician's assessment
  • Partners of participants may not be able to join if they decline to sign the informed consent form, have cognitive impairment, or have a severe mental illness that would prevent them from giving informed consent or completing study activities, based on a clinician's assessment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
5 July 2024
Est. completion
16 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Accrual rate (AR); Retention rate (RR); Adherence rate (AdR); Study Satisfaction (SS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov